These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 28630042)

  • 21. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.
    Liu X; Zhang Y; Zhuang L; Olszewski K; Gan B
    Genes Dis; 2021 Nov; 8(6):731-745. PubMed ID: 34522704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
    Habib E; Linher-Melville K; Lin HX; Singh G
    Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of SLC7A11/xCT in Ovarian Cancer.
    Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
    Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity.
    Tan SLW; Tan HM; Israeli E; Fatihah I; Ramachandran V; Ali SB; Goh SJA; Wee J; Tan AQL; Tam WL; Han W
    Biochem J; 2023 Dec; 480(24):2045-2058. PubMed ID: 38078799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells.
    Yan Y; Teng H; Hang Q; Kondiparthi L; Lei G; Horbath A; Liu X; Mao C; Wu S; Zhuang L; James You M; Poyurovsky MV; Ma L; Olszewski K; Gan B
    Nat Commun; 2023 Jun; 14(1):3673. PubMed ID: 37339981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glial Glutamate Transporter-Mediated Plasticity: System x
    Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. System Xc
    Wang M; Li B; Meng W; Chen Y; Liu H; Zhang Z; Li L
    Oral Dis; 2024 Jul; 30(5):2952-2964. PubMed ID: 37856618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells.
    Yamaguchi I; Katoh H
    J Biochem; 2024 Mar; 175(3):313-322. PubMed ID: 38102738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
    Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystine/glutamate antiporter xCT controls skeletal muscle glutathione redox, bioenergetics and differentiation.
    Kanaan MN; Pileggi CA; Karam CY; Kennedy LS; Fong-McMaster C; Cuperlovic-Culf M; Harper ME
    Redox Biol; 2024 Jul; 73():103213. PubMed ID: 38815331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
    Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
    Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
    Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BAP1 links metabolic regulation of ferroptosis to tumour suppression.
    Zhang Y; Shi J; Liu X; Feng L; Gong Z; Koppula P; Sirohi K; Li X; Wei Y; Lee H; Zhuang L; Chen G; Xiao ZD; Hung MC; Chen J; Huang P; Li W; Gan B
    Nat Cell Biol; 2018 Oct; 20(10):1181-1192. PubMed ID: 30202049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SLC7A11 negatively associates with mismatch repair gene expression and endows glioblastoma cells sensitive to radiation under low glucose conditions.
    Hu N; Hu WH; Zhou SL; Yang Z; Liang WL; Yang RY; Li MH; Jing Z; Li ZA; Fu XD; Wang XJ
    Neoplasma; 2021 Nov; 68(6):1147-1156. PubMed ID: 34427100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
    Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT/SLC7A11 in human placental BeWo cells.
    Ono K; Furugen A; Kurosawa Y; Jinno N; Narumi K; Kobayashi M; Iseki K
    Placenta; 2019 Jan; 75():34-41. PubMed ID: 30712664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.
    Sehm T; Rauh M; Wiendieck K; Buchfelder M; Eyüpoglu IY; Savaskan NE
    Oncotarget; 2016 Nov; 7(46):74630-74647. PubMed ID: 27612422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
    Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
    J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of the Inhibitor Targeting the SLC7A11/xCT Axis through In Silico and In Vitro Experiments.
    Yue J; Yin Y; Feng X; Xu J; Li Y; Li T; Liang S; He X; Liu Z; Wang Y
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.